SGHT Sight Sciences, Inc Company Total Asset Base

Official company branding of Sight Sciences Inc. (SGHT)

Sight Sciences, Inc. (SGHT) generates revenue by developing ophthalmological systems, promoting high-margin tools for treating glaucoma and eyelid gland pathologies. This market valuation chart shows total assets at 113.41. The company's pricing power relies on procedural efficiency, although it remains dependent on Medicare insurance reimbursements. Meanwhile, the business faces intense pressure from medtech behemoths offering comprehensive solutions.

Sight Sciences, Inc - SGHT Company Total Assets (period 07/04/2022 - 10/31/2026)

Financial and market metric breakdowns for Sight Sciences, Inc (SGHT)

- share price and expert price forecast:
Price sightsciences.com|SGHT - Price Target Chart
- market capitalization data:
Market Capitalization Sight Sciences Inc|SGHT - Total Company Value
- shareholders' equity book value data:
Share Book Value Sight Sciences, Inc.|SGHT - Book Capitalization|Market-to-Book Ratio sightsciences.com|SGHT - Company Total Assets
- debt and liquidity details:
Total Debt to Equity Ratio Sight Sciences, Inc.|SGHT - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Sight Sciences Inc|SGHT - Company Aggregate Debts|Debts to Book Capitalization Sight Sciences Inc|SGHT - Company Long-Term Debt|Company Short-Term Debt Sight Sciences, Inc.|Interim Coverage Ratio sightsciences.com
- financial results and valuation multiples details:
SGHT - Net Income
Fundamental valuation:Sight Sciences, Inc.
Core merchandise of Sight Sciences, Inc.

The selection of the issuer is based on an analysis of fundamental multiples that determine business stability. Total assets, reverse-calculated via ROA, reflect the aggregate value of the company's resources, allowing for the tracking of basis dynamics between quarterly reports. For Sight Sciences, Inc. (SGHT), this volume is critical when financing clinical trials and fighting for insurance coverage in the glaucoma treatment segment. By analyzing the changes in the company's financial assets on GURU.Markets, an investor assesses the business's ability to scale amidst fierce competition.

Main competitors

BSX: Aggregate Business Assets|Aggregate Company Assets Edwards Lifesciences Corporation|ResMed Inc (RMD) - Company Total Asset Base|Aggregate Company Assets OmniPod (PODD)|ZBH: Total Asset Value of Company|Company Total Assets COO (The Cooper Companies)|aligntech.com (ALGN) - Company Assets|Globus Medical - Company Total Assets|transmedics.com (TMDX) - Cumulative Company Assets|ATEC: Company Total Assets|AORT - Company Total Asset Base|ENOV (Enovis Corporation) - Company Total Assets|Company Total Assets integralife.com|Aggregate Company Assets Establishment Labs Holdings Inc. (ESTA)|Aggregate Company Assets BBNX (Beta Bionics, Inc.)|Company Total Assets IRMD (Iradimed)|Company Total Asset Base Embecta Health (EMBC)|TNDM: Cumulative Company Assets|Total Asset Value of Company AXGN|SIBN: Company Total Assets|Company Assets Orthofix Medical (OFIX)|BVS (Bioventus Corp) - Company Total Assets|Total Business Assets KIDS (OrthoPediatrics Inc.)|Cumulative Company Assets TMCI (Treace Medical Concepts)|SRTA (blade.com) - Aggregate Asset Value|Aggregate Company Assets Carlsmed CARL|RXST - Cumulative Company Assets|ClearPoint - Company Total Assets|Company Assets Stereotaxis Corporation|STIM: Company Total Assets|Total Business Assets OBIO|ANIK (Anika Therapeutics Inc.) - Company Total Assets|InspireMD Inc (NSPR) - Company Total Asset Base|Company Total Assets ZJYL|Cumulative Company Assets vivani.com VANI|Company Total Assets XTNT (Xtant Medical)|Company Total Assets n1mtc.com NMTC|MODD - Aggregate Company Assets|MYO: Aggregate Company Assets|COCH (Envoy Medical, Inc) - Cumulative Company Assets|Vivos Therapeutics Inc - Aggregate Asset Value|NVNO (enVVeno Medical) - Company Total Assets|Company Assets SINTX Technologies SINT|Aggregate Company Assets Tenon Medical (TNON)|ReWalk Robotics (LFWD) - Company Balance Sheet Assets|Autonomix Medical - Cumulative Company Assets|Company Total Assets INVO Fertility Corp IVF|Bone Biologics - Company Total Assets|Company Total Asset Base axonics.com AXNX|BIOLASE (BIOL) - Aggregate Company Assets|Total Asset Value of Company DYNT (Dynatronics)|Aggregate Company Assets Paragon 28 Inc.|Cumulative Company Assets INVO Bio (INVO)